The Clorox (CLX) Fundamental Analysis: Revenue, Earnings & Valuation

3.83 / 10

Netural

Fundamentally, CLX scores 3.8/10, indicating poor health. Asset‑MV and equity multiplier are strengths, but cash growth and PB‑ROE are weak, resulting in a neutral overall fundamental rating.

Analysis Checks(5/10)

Operating cycle

Value92.07

Score1/3

Weight3.38%

1M Return1.40%

Equity multiplier

Value17.32

Score2/3

Weight5.60%

1M Return2.22%

Equity ratio (Total liabilities / Shareholders’ equity attributable to parent company) (%)

Value15.82

Score2/3

Weight5.60%

1M Return2.22%

Profit-MV

Value-0.43

Score1/3

Weight6.92%

1M Return2.96%

Net income-Revenue

Value0.45

Score2/3

Weight24.25%

1M Return7.42%

PB-ROE

Value1.17

Score0/3

Weight-1.09%

1M Return-0.62%

Cash-UP

Value-0.08

Score0/3

Weight2.35%

1M Return0.88%

Cost of sales ratio (%)

Value54.77

Score2/3

Weight4.04%

1M Return1.51%

Asset-MV

Value-0.69

Score3/3

Weight41.62%

1M Return15.60%

Cash-MV

Value0.05

Score0/3

Weight7.34%

1M Return2.52%

Is CLX fundamentally strong?

CLX scores 3.83/10 on fundamentals and holds a Fair valuation at present. Backed by its 91.68% ROE, 11.39% net margin, 16.36 P/E ratio, 352.89 P/B ratio, and 66.40% earnings growth, these metrics solidify its Netural investment rating.